Clarks Nutrition and Natural Foods Markets

Search Healthnotes

Tildrakizumab-Asmn

Pronounced

"TIL-dra-KIZ-ue-mab-ASMN"

Common brand names:

Ilumya

Uses

This medication is used to treat moderate to severe plaque psoriasis. Tildrakizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.

How to Use This Medication

Read the Medication Guide provided by your pharmacist before you start using tildrakizumab and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

Before treatment with this medication, your doctor will test you for tuberculosis (TB). Your doctor should also monitor you for symptoms of TB during and after treatment with this drug. If needed, treatment for tuberculosis or other infections should be given before receiving this medication.

This medication is given by injection under your skin by a health care professional. It is given as directed by your doctor. After the first dose, another dose is usually given 4 weeks later, followed by doses every 12 weeks. The injection is given in the upper arms, thighs, or abdomen (at least 2 inches from your belly button). The dosage is based on your medical condition and response to treatment.

The injection site should be changed each time to lessen injury under the skin. Your health care provider should avoid injecting under skin that is tender, bruised, red, hard, thick, scaly, or affected by psoriasis. To lessen bruising, do not rub the injection site after a shot.

Use this medication regularly to get the most benefit from it. It may help to mark your calendar with a reminder.

Tell your doctor if your condition does not get better or if it gets worse.

RxAnswers™ is a copyrighted combined product from TraceGains and First DataBank, Inc.

Drug information is selected from data included with permission and copyrighted by First DataBank, Inc. This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional. Always seek the advice of your healthcare professional if you have any questions about this product or your medical condition. This information is not intended as individual medical advice and does not substitute for the knowledge and judgment of your healthcare professional. This information does not contain any assurances that this product is safe, effective or appropriate for you.

This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.

Learn more about First DataBank

There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.

Learn more about TraceGains, the company.

TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.

Information expires December 2024.